Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve approval of audited financials ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences Ltd has informed BSE that a Board of Directors meeting is scheduled for Monday, May 26, 2025 at its corporate office in New Delhi. The main agenda is to consider and approve the Audited Financial Results of the company for the quarter and financial year ended March 31, 2025, as required under SEBI Listing Regulations. The filing also notes that the trading window for dealing in the company's securities is already closed for insiders since April 1, 2025 and will reopen 48 hours after the results are declared. The intimation has been signed by Sameer Goel, Managing Director. No financial figures have been disclosed in this filing.
This is a routine advance intimation and does not contain any actual earnings data — investors should wait for the audited results to be published on or after May 26, 2025 to gauge the company's FY25 performance. The closed trading window signals that insider activity is restricted until results are out.